{"name":"Shanghai Haiyan Pharmaceutical Technology Co., Ltd.","slug":"shanghai-haiyan-pharmaceutical-technology-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Experimental: YZJ-4729","genericName":"Experimental: YZJ-4729","slug":"experimental-yzj-4729","indication":"Other","status":"phase_3"},{"name":"YZJ-5053 tablets","genericName":"YZJ-5053 tablets","slug":"yzj-5053-tablets","indication":"Other","status":"phase_1"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Active Comparator: Morphine","genericName":"Active Comparator: Morphine","slug":"active-comparator-morphine","indication":"Moderate to severe acute pain","status":"phase_3"}]},{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"YZJ-1139","genericName":"YZJ-1139","slug":"yzj-1139","indication":"Type 2 diabetes","status":"phase_3"}]}],"pipeline":[{"name":"Experimental: YZJ-4729","genericName":"Experimental: YZJ-4729","slug":"experimental-yzj-4729","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"YZJ-5053 tablets","genericName":"YZJ-5053 tablets","slug":"yzj-5053-tablets","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Active Comparator: Morphine","genericName":"Active Comparator: Morphine","slug":"active-comparator-morphine","phase":"phase_3","mechanism":"Morphine binds to opioid receptors in the central and peripheral nervous system to produce analgesia and sedation.","indications":["Moderate to severe acute pain","Moderate to severe chronic pain","Cancer pain"],"catalyst":""},{"name":"YZJ-1139","genericName":"YZJ-1139","slug":"yzj-1139","phase":"phase_3","mechanism":"YZJ-1139 is a small molecule drug that targets the SGLT2 receptor.","indications":["Type 2 diabetes","Heart failure"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNZ1Q4UjZiVDdkc0FDRkszV19BN1ZudlREN2NKNjRtMG5zUlg5NVFCamFXMEd2b05faDF4YTFqbW1SWUpqelJMNDVHR0RSQVFZUWpodXF3eTR4QjhZaTB0WkFCRzhmeGM4VGd4MmZtQVJLMXVrNFk1dUhKRGFXRVRRRmpoWVNjR1NOTzFsTW54RDRpaDA3bjY0QVVXdktocUU5RTV3THV6NGdZbmN5UjNhUVZkRjQ1Uk5sLTZuekpIcHpWN3NkbWlmZkRoWU9zQVhPbDViVUdVN0JTVkZSdUgyemZLSmt2SnFyaFRsbg?oc=5","date":"2026-04-02","type":"pipeline","source":"Barchart.com","summary":"Chronic and Acute Pain Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight - Barchart.com","headline":"Chronic and Acute Pain Treatment Pipeline Shows Strong Momentum as 180+ Pharma Companies in the Race | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAJBVV95cUxPbTQ4dFNtN3ZWMHZHY1NwMmgzbVZvVzF0VElQNWVWWXVHQ1BjTXIxTmQ4VWY4RGdfVlFVYkU0LVBPbHZJQThMQmRHRGFYc19yYXZOeFJVSjh2UFNoR2hfT0tHZmZYdmdpVDJlOWtnQklZSERqdWxidWtvVjJCLWQyMVladEh4b0hsZ0lXZGRkWXFsc1FLU1hjWkdDdmx3WmNSQ0FfT1FGcmIxejI3Rnk3LWpCbm8yNS0xQmUtVFRsajhtTHdrWkZ6S3gwNTNxd1cxTkE3RWZnS2t6V3FLY2FUN2JQbGRrVWlMY1kzRkdRcUVVMms3WUhPQnhCbkwzeWxsRnFva0oyVEVjdUx6ZTAycFBQakh0dXVSRENRb2hfTjBoNEtUOTZGdGtNem5nemJBaEQ0elRhT245eG9H?oc=5","date":"2026-01-28","type":"trial","source":"GlobeNewswire","summary":"Chronic and Acute Pain Clinical Trial Pipeline Analysis: - GlobeNewswire","headline":"Chronic and Acute Pain Clinical Trial Pipeline Analysis:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPYkUtWU5iZnpoMlFnNWJSSTVSMG5qVGRITzV3NWVscUR2MDBwQVFrUnYzWHJCVC1qT0g4V3VtOGlvanB4a25sMThsQVdEN0pnUEtNcU9qcFRuSEZubUtoVDI2aVc5UlRVTjFkNFlxYWY3Sld2UFltZGs0dVJJakpIb290cWNFVTg?oc=5","date":"2025-09-23","type":"pipeline","source":"BioWorld News","summary":"Genfleet raises $234M with Hong Kong IPO - BioWorld News","headline":"Genfleet raises $234M with Hong Kong IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFAtdzFadGo1cnZ3am9XMi1wV2F1bVBYbXU0NDBFMngzMFYteWxfWklCLU9XWUJ5cjhyVHdJX25nWllUXzg5cENtRWh0TnpPSkYtc0pISkcwYmtMUzhVZnF1MHZCbll6LUdQUmZybGYwdkNZWWJSU0dyMXkzUURFUQ?oc=5","date":"2023-12-02","type":"pipeline","source":"China Daily","summary":"Novartis to set up new drug plant - China Daily","headline":"Novartis to set up new drug plant","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_3":3,"phase_1":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}